<abstract xmlns="http://www.w3.org/1999/xhtml">

<p>In this commentary/short communication we build upon our existing research and viewpoints related to the deleterious effects that AAS/Androgen use has, and the growing body of work and case studies/reports that identify the substantially increased risks that AAS/Androgen use presents to those who have (or have had) COVID-19. We position this commentary/short communication then, as one that builds on our prior calls for public health policy to be in part framed by, or at least to recognise the risks, of AAS/Androgen use. This is of particular contemporary importance now that COVID-19 is endemic, and we report on how long COVID-19 (Post COVID-19 syndrome) can present a wide range of lasting <italic>c</italic>ardiovascular problems, a particular issue given that AAS/Androgen use may well exacerbate future health risks aligned to COVID-19.</p>
</abstract>

In this commentary/short communication we build upon our existing research and viewpoints related to the deleterious effects that AAS/Androgen use has, and the growing body of work and case studies/reports that identify the substantially increased risks that AAS/Androgen use presents to those who have (or have had) COVID-19. We position this commentary/short communication then, as one that builds on our prior calls for public health policy to be in part framed by, or at least to recognise the risks, of AAS/Androgen use. This is of particular contemporary importance now that COVID-19 is endemic, and we report on how long COVID-19 (Post COVID-19 syndrome) can present a wide range of lasting cardiovascular problems, a particular issue given that AAS/Androgen use may well exacerbate future health risks aligned to COVID-19.

Heart Disease After Covid: Exacerbated Future Health Risks Aligned to Previous and Existing AAS/Androgen Use

Oxford Brookes University, Headington Road Oxford

Acta Facultatis Educationis Physicae Universitatis Comenianae

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

In this commentary/short communication we build upon our existing research and viewpoints related to the deleterious effects that AAS/Androgen use has, and the...

Heart Disease After Covid: Exacerbated Future Health Risks Aligned to Previous and Existing AAS/Androgen Use

Publié en ligne: 16 nov. 2022

Pages: 134 - 141

DOI: https://doi.org/10.2478/afepuc-2022-0012

Mots clés
Post COVID-19 Syndrome, Myocardial Dysfunction, Public Health Policy, Anabolic-Androgenic Steroids (AAS)/Androgens

© 2022 Philippe Crisp et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Heart Disease After Covid: Exacerbated Future Health Risks Aligned to Previous and Existing AAS/Androgen Use

Publié en ligne: 16 nov. 2022

Pages: 134 - 141

DOI: https://doi.org/10.2478/afepuc-2022-0012

Mots clésPost COVID-19 Syndrome, Myocardial Dysfunction, Public Health Policy, Anabolic-Androgenic Steroids (AAS)/Androgens

© 2022 Philippe Crisp et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Mots clés
Post COVID-19 Syndrome, Myocardial Dysfunction, Public Health Policy, Anabolic-Androgenic Steroids (AAS)/Androgens